Annual golf day drives success
The annual Weston Park Cancer Charity golf day, sponsored by Special Steel Group, has raised over £37,000 pounds for Weston Park Hospital – the region’s only specialist cancer hospital.
Businesses across the region chipped in for Weston Park Cancer Charity’s Golf Day which took place on Friday 13th July, at the picturesque Hallam shire Golf Course. On the day, over 58 teams, comprising mainly of local business, united to raise funds for cancer patients locally.
Alan Beardshaw, Special Steel Group, said: “We recognise just how important the work Weston Park Hospital is and are delighted to support this event. Luckily, we have never needed to use the hospital, but we are thankful to know that is there should our friends or family require its specialist services. We are incredibly fortunate to have this hospital in Sheffield.”
Samantha Dixon, CEO at Weston Park Cancer Charity, commented: “Weston Park Cancer Charity’s golf day was founded by John Price who started fundraising as a thank you for the life-saving cancer treatment he received at Weston Park Hospital. Since then, John and his family have worked tirelessly to establish the event as we know it today. We are extremely grateful for their continued support alongside the generosity of the event sponsor, Special Steel Group and Hallamshire Golf Club.
“We are absolutely delighted that so many teams joined us on the course, to raise vital funds so that people in our region can access to the very best cancer care services.”
Weston Park Hospital is the region’s only specialist cancer hospital, providing care for thousands of cancer patients across South Yorkshire, North Derbyshire and North Nottinghamshire.
Over the years, Weston Park Cancer Charity has played a pivotal role in bringing world-class treatments and research to Weston Park Hospital, giving patients access to the latest advances in the treatment of the disease. Not only does this improve the quality of cancer services across the board but helps Weston Park’s world-leading clinicians better understand the disease, paving the way for the hope of one day finding a cure.